From Name:
From Email:
To Name:
To Email:

Optional Message:


Biological fingerprint identifies leiomyomatosis and renal cell cancer

from LabMedica

A diagnostic test involves screening tumor samples for a particular molecular fingerprint unique to leiomyomatosis and renal cell cancer (HLRCC). A protein modification induced by FH deficiency (due to an over-abundance of fumarate) was identified by scientists at the Henry Wellcome Building for Molecular Physiology, University of Oxford (United Kingdom). more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063